免疫系を若返らせる新しい方法を発見:肝臓を刺激してT細胞機能を回復 (New study suggests way to rejuvenate immune system)

ad

2025-12-17 マサチューセッツ工科大学(MIT)

マサチューセッツ工科大学(MIT)とブロード研究所の研究チームは、年齢とともに低下する免疫機能を回復する新たな手法をマウス実験で示した。加齢により胸腺が萎縮すると、T細胞の生成や多様性が低下し、感染や疾患への抵抗力が弱まる。研究では、mRNAを使って肝臓細胞に胸腺が通常分泌する主要なシグナル因子を一時的に作らせることで、加齢マウスのT細胞数と多様性を増加させ、ワクチン反応性や癌免疫療法への反応を高めた。具体的には、mRNAで3種類の因子を肝臓に導入し、これが一時的な「免疫若返り工場」として機能することで、老化免疫機能が補われた。この戦略は、加齢に伴う免疫低下(免疫老化)を克服し、高齢者の感染防御や免疫療法の効果向上につながる可能性を示しており、将来的な臨床応用の展望がある。

<関連情報>

肝臓における栄養因子の一過性再構成は高齢者の免疫力を高める Transient hepatic reconstitution of trophic factors enhances aged immunity

Mirco J. Friedrich,Julie Pham,Jiakun Tian,Hongyu Chen,Jiahao Huang,Niklas Kehl,Sophia Liu,Blake Lash,Fei Chen,Xiao Wang,Rhiannon K. Macrae & Feng Zhang
Nature  Published:17 December 2025
DOI:https://doi.org/10.1038/s41586-025-09873-4

免疫系を若返らせる新しい方法を発見:肝臓を刺激してT細胞機能を回復 (New study suggests way to rejuvenate immune system)

Abstract

Ageing erodes human immunity, in part by reshaping the T cell repertoire, leading to increased vulnerability to infection, malignancy and vaccine failure1,2,3. Attempts to rejuvenate immune function have yielded only modest results and are limited by toxicity or lack of clinical feasibility1,3,4,5. Here we show that the liver can be transiently repurposed to restore age-diminished immune cues and improve T cell function in aged mice. These immune cues were found by performing multi-omic mapping across central and peripheral niches in young and aged animals, leading to the identification of Notch and Fms-like tyrosine kinase 3 ligand (FLT3L) pathways, together with interleukin-7 (IL-7) signalling, as declining with age. Delivery of mRNAs encoding Delta-like ligand 1 (DLL1), FLT3L and IL-7 to hepatocytes expanded common lymphoid progenitors, boosted de novo thymopoiesis without affecting haematopoietic stem cell (HSC) composition, and replenished T cells while enhancing dendritic cell abundance and function. Treatment with these mRNAs improved peptide vaccine responses and restored antitumour immunity in aged mice by increasing tumour-specific CD8+ infiltration and clonal diversity and synergizing with immune checkpoint blockade. These effects were reversible after dosing ceased and did not breach self-tolerance, in contrast to the inflammatory and autoimmune liabilities of recombinant cytokine treatments6,7. These findings underscore the promise of mRNA-based strategies for systemic immune modulation and highlight the potential of interventions aimed at preserving immune resilience in ageing populations.

細胞遺伝子工学
ad
ad
Follow
ad
タイトルとURLをコピーしました